Leprosy Mailing List – January 21st, 2010
Ref.: Alternative antibiotic regimens for leprosy
From: Wim H. van Brakel
Dear Dr. Gilead,
Unless there is suspicion of antibiotic resistance to either dapsone or rifampicin, it is not necessary to replace the clofazimine component of MB MDT. People get better on double drug therapy just as well as they do on MDT, because most of the MDT effect is due to rifampicin. The only time you will miss the clofazimine component is when a patient is prone to develop ENL. We see many former patients nowadays who develop ENL reactions after their 12-month regimen has been completed, just due to the withdrawal of clofazimine.
With friendly greetings,
Wim van Brakel
Wim H. van Brakel, MD MSc PhD
Royal Tropical Institute
Leprosy Unit
and
Athena Institute
Faculty of Earth and Life Sciences
VU University
Correspondence address:
Wibautstraat 137k
1097DN
tel +3120 6939297
fax +3120 6680823
w.v.brakel(at)kit.nl
No comments:
Post a Comment